Susquehanna International Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Buy
25,500
+4,400
+21% +$2.82M ﹤0.01% 2620
2025
Q4
$14.3M Sell
21,100
-45,800
-68% -$31.2M ﹤0.01% 2596
2025
Q3
$42.7M Buy
66,900
+12,600
+23% +$7.65M ﹤0.01% 1465
2025
Q2
$29.1M Buy
54,300
+36,800
+210% +$17.6M ﹤0.01% 1636
2025
Q1
$7.35M Sell
17,500
-156,300
-90% -$67.9M ﹤0.01% 2959
2024
Q4
$71.9M Buy
173,800
+109,200
+169% +$47.9M 0.01% 895
2024
Q3
$32.6M Sell
64,600
-42,800
-40% -$20.8M 0.01% 1405
2024
Q2
$52.3M Sell
107,400
-68,000
-39% -$34.1M 0.01% 955
2024
Q1
$94.7M Buy
175,400
+100,700
+135% +$55M 0.02% 703
2023
Q4
$41.5M Sell
74,700
-19,700
-21% -$9.25M 0.01% 1164
2023
Q3
$41.3M Buy
94,400
+16,100
+21% +$8.03M 0.01% 1141
2023
Q2
$39.3M Sell
78,300
-86,200
-52% -$41.3M 0.01% 1164
2023
Q1
$82.3M Buy
164,500
+14,400
+10% +$6.89M 0.02% 677
2022
Q4
$61.2M Buy
150,100
+58,600
+64% +$22.7M 0.02% 777
2022
Q3
$29.8M Buy
91,500
+12,300
+16% +$4.52M 0.01% 1112
2022
Q2
$27.8M Sell
79,200
-7,600
-9% -$3.1M 0.01% 1204
2022
Q1
$47.5M Buy
86,800
+33,900
+64% +$17.8M 0.01% 1029
2021
Q4
$34.8M Sell
52,900
-108,400
-67% -$68M 0.01% 1367
2021
Q3
$100M Sell
161,300
-19,700
-11% -$13.2M 0.01% 784
2021
Q2
$114M Buy
181,000
+8,500
+5% +$4.69M 0.02% 727
2021
Q1
$84.4M Buy
172,500
+111,900
+185% +$56.1M 0.01% 808
2020
Q4
$30.3M Buy
60,600
+10,000
+20% +$4.47M ﹤0.01% 1361
2020
Q3
$19.9M Buy
50,600
+13,000
+35% +$4.81M ﹤0.01% 1487
2020
Q2
$12.4M Sell
37,600
-15,000
-29% -$4.34M ﹤0.01% 1900
2020
Q1
$12.7M Sell
52,600
-11,200
-18% -$2.92M ﹤0.01% 1519
2019
Q4
$16.7M Buy
63,800
+25,000
+64% +$6.59M ﹤0.01% 1591
2019
Q3
$10.6M Sell
38,800
-6,400
-14% -$1.78M ﹤0.01% 1923
2019
Q2
$12.4M Sell
45,200
-31,000
-41% -$7.64M ﹤0.01% 1684
2019
Q1
$17M Sell
76,200
-8,900
-10% -$1.84M 0.01% 1302
2018
Q4
$15.8M Buy
85,100
+27,000
+46% +$5.54M 0.01% 1229
2018
Q3
$14.5M Sell
58,100
-7,300
-11% -$1.77M ﹤0.01% 1591
2018
Q2
$14.3M Buy
65,400
+9,600
+17% +$1.98M ﹤0.01% 1603
2018
Q1
$10.7M Sell
55,800
-13,500
-19% -$2.49M ﹤0.01% 1715
2017
Q4
$10.8M Buy
69,300
+1,800
+3% +$283K ﹤0.01% 1753
2017
Q3
$10.5M Sell
67,500
-38,500
-36% -$6.09M ﹤0.01% 1734
2017
Q2
$17.1M Buy
106,000
+12,200
+13% +$1.98M 0.01% 1269
2017
Q1
$14.5M Buy
93,800
+21,700
+30% +$2.99M 0.01% 1323
2016
Q4
$8.46M Buy
72,100
+6,600
+10% +$753K ﹤0.01% 1722
2016
Q3
$7.38M Buy
65,500
+36,600
+127% +$3.86M ﹤0.01% 1801
2016
Q2
$2.68M Buy
28,900
+9,600
+50% +$824K ﹤0.01% 3092
2016
Q1
$1.51M Buy
19,300
+6,400
+50% +$461K ﹤0.01% 4284
2015
Q4
$941K Sell
12,900
-10,700
-45% -$763K ﹤0.01% 5532
2015
Q3
$1.75M Sell
23,600
-22,100
-48% -$1.58M ﹤0.01% 4535
2015
Q2
$2.93M Sell
45,700
-300
-0.7% -$20.8K ﹤0.01% 3901
2015
Q1
$3.55M Buy
46,000
+15,000
+48% +$1.17M ﹤0.01% 3257
2014
Q4
$2.3M Sell
31,000
-5,400
-15% -$379K ﹤0.01% 4188
2014
Q3
$2.15M Buy
36,400
+13,600
+60% +$860K ﹤0.01% 4487
2014
Q2
$1.52M Buy
22,800
+1,000
+5% +$63.6K ﹤0.01% 5198
2014
Q1
$1.32M Sell
21,800
-3,000
-12% -$179K ﹤0.01% 5021
2013
Q4
$1.32M Hold
24,800
﹤0.01% 4989
2013
Q3
$1.24M Sell
24,800
-56,800
-70% -$2.73M ﹤0.01% 4928
2013
Q2
$3.66M Buy
+81,600
New +$3.57M ﹤0.01% 3031

Other funds holding IDXX

Susquehanna International Group's IDXX Position: Q1 2026 in Review

Susquehanna International Group reduced its Idexx Laboratories (IDXX) stake by 30% in Q1 2026, selling an estimated $3.85M and leaving 14,061 shares worth $7.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3482.

Susquehanna International Group first reported a position in IDXX in Q2 2013 and has held it in 47 quarters since. The position peaked at $35.9M in Q2 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Susquehanna International Group held 14,061 shares of Idexx Laboratories worth $7.9M as of Q1 2026.
  • Susquehanna International Group sold 6,003 Idexx Laboratories shares in Q1 2026, an estimated $3.85M.
  • Idexx Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3482 holding.
  • Susquehanna International Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Idexx Laboratories position peaked at $35.9M in Q2 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.